• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Phibro Animal Health Corporation (PAHC) Stock Price, News & Analysis

Phibro Animal Health Corporation (PAHC) Stock Price, News & Analysis

Currency in USD Disclaimer

$23.74

$0.35

(1.5%)

Day's range
$23.19
Day's range
$24.74
50-day range
$20.86
Day's range
$25.98
  • Country: US
  • ISIN: US71742Q1067
52 wk range
$9.49
Day's range
$25.98
  • CEO: Mr. Jack Clifford Bendheim
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.97
  • Piotroski Score 7.00
  • Grade Underweight
  • Symbol (PAHC)
  • Company Phibro Animal Health Corporation
  • Price $23.74
  • Changes Percentage (1.5%)
  • Change $0.35
  • Day Low $23.19
  • Day High $24.74
  • Year High $25.98

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

  • Last Earnings 11/05/2024
  • Ex-Dividend for 5/16 Dividend 11/27/2024
  • Dividend Payable 12/18/2024
  • Today N/A
  • Next Earnings (Estimated) 02/05/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $18.00
  • High Stock Price Target $21.00
  • Low Stock Price Target $17.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.33
  • Trailing P/E Ratio 52
  • Forward P/E Ratio 52
  • P/E Growth 52
  • Net Income $2.42 M

Income Statement

Quarterly

Annual

Latest News of PAHC

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Phibro Animal Health Corporation Frequently Asked Questions

  • What were the earnings of PAHC in the last quarter?

    In the last quarter Phibro Animal Health Corporation earnings were on Thursday, November, 7th. The Phibro Animal Health Corporation maker reported $0.35 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.10.

  • What is the Phibro Animal Health Corporation stock price today?

    Today's price of Phibro Animal Health Corporation is $23.74 — it has increased by +1.5% in the past 24 hours. Watch Phibro Animal Health Corporation stock price performance more closely on the chart.

  • Does Phibro Animal Health Corporation release reports?

    Yes, you can track Phibro Animal Health Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Phibro Animal Health Corporation stock forecast?

    Watch the Phibro Animal Health Corporation chart and read a more detailed Phibro Animal Health Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is Phibro Animal Health Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Phibro Animal Health Corporation stock ticker.

  • How to buy Phibro Animal Health Corporation stocks?

    Like other stocks, PAHC shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Phibro Animal Health Corporation's EBITDA?

    Phibro Animal Health Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Phibro Animal Health Corporation’s financial statements.

  • What is the Phibro Animal Health Corporation's net income ratio for the financial year 2024?

    The net income ratio for the financial year 2024 is 0.0023740295, which equates to approximately 0.24%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Phibro Animal Health Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Phibro Animal Health Corporation's financials relevant news, and technical analysis. Phibro Animal Health Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Phibro Animal Health Corporation stock currently indicates a “sell” signal. For more insights, review Phibro Animal Health Corporation’s technical analysis.

  • A revenue figure for Phibro Animal Health Corporation for its last quarter?

    Phibro Animal Health Corporation published it's last quarterly revenues at $260.43 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.